Beken Bio
PrivateLast Round
Seed
Dec 10, 2026
Total Funding Raised
$2.28M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beken Bio operates in Healthcare & Life Sciences and is based in New Orleans, Louisiana. Its latest recorded funding round was a Seed round in December 2026.
Beken Bio is a biotechnology company that develops minimally invasive liquid biopsy diagnostic tests for early cancer detection using AI-driven protein analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beken Bio Comparables
Compare Beken Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOA Dx | 81% | |
| Dxcover | 77% | |
| InterVenn Biosciences | 77% |
For institutional investors. Book with your work email.
Beken Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 10, 2026 | ||||
| Grant | Aug 11, 2026 | ||||
| Grant | Aug 15, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Beken Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Community Development Venture Capital Alliance | Seed |
| Boot64 Ventures | Seed |
| New Orleans BioFund | Seed |
| Tulane Ventures | Seed |
| 1834 Ventures | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 10, 2026
$750K raised from 1834 Ventures and others.
- Aug 11, 2026
$1.25M grant from the National Science Foundation
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 13, 2026
Beken Bio, Inc. is developing a liquid biopsy that uses a simple blood test to identify cancer-related extracellular vesicles, with Phase II funding supporting testing in real patients across Louisiana.
- is_developingAug 11, 2026
Beken Bio, Inc. combines nanobiology with machine learning and artificial intelligence to develop approaches to early cancer detection by targeting abundant biomarkers and providing objective molecular information.
- receives_financingAug 11, 2026
Beken Bio, Inc. receives a $1.25M National Science Foundation Phase II SBIR grant to advance a blood test for earlier cancer detection, test it in about 300 patients, and explore other hard-to-detect cancers in Louisiana.
For institutional investors. Book with your work email.
Beken Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beken Bio's valuation, stock price, and market status.
Is Beken Bio a public or private company?
Beken Bio is a private company.
What is the current stock price of Beken Bio?
Beken Bio is a private company, so its shares have no public market price. Caplight tracks Beken Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beken Bio worth (valuation)?
Valuation information for Beken Bio is not publicly available.
Can I buy Beken Bio stock?
Beken Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beken Bio's last funding round?
Beken Bio's most recent funding round was Seed on December 10, 2026.
Who are the main investors in Beken Bio?
Key investors in Beken Bio include Community Development Venture Capital Alliance, Boot64 Ventures, New Orleans BioFund, Tulane Ventures, 1834 Ventures.
Will Beken Bio IPO soon?
No public IPO plans have been announced for Beken Bio.
How can I track Beken Bio secondary market activity?
Caplight tracks bids, offers, and trades in Beken Bio's shares on secondary markets.